Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India.
AAPS PharmSciTech. 2010 Sep;11(3):1223-31. doi: 10.1208/s12249-010-9477-x. Epub 2010 Aug 4.
The objective of the present study was to prepare mucoadhesive in situ nasal gels with mucilage isolated from fig fruits (Ficus carica, family: Moraceae) containing midazolam hydrochloride. Nasal gels of midazolam were prepared using three different concentrations (0.5%, 1.0% and 1.5% w/v) of F. carica mucilage (FCM) and synthetic polymers (hydroxypropylmethyl cellulose and Carbopol 934). Evaluation of FCM showed that it was as safe as the synthetic polymers for nasal administration. In situ gels were prepared with mixture Pluronic F127 and mucoadhesive agents. Evaluation of the prepared gels was carried out, including determination of viscosity, texture profile analysis and mucoadhesive strength. In vitro drug permeation study was conducted with the gels prepared with and without permeation enhancer (0.5% w/v sodium taurocholate) using excised goat nasal mucosa. In vitro permeation profiles were evaluated, and histological study of nasal mucosae before and after permeation study was also conducted to determine histological change, if any. In vivo experiments conducted in rabbits further confirmed that in situ nasal gels provided better bioavailability of midazolam than the gels prepared from synthetic mucoadhesive polymers. It was observed that the nasal gel containing 0.5% FCM and 0.5% sodium taurocholate exhibited appropriate rheological, mechanical and mucoadhesive properties and showed better drug release profiles. Moreover, this formulation produced no damage to the nasal mucosa that was used for the permeation study, and absolute bioavailability was also higher compared to gels prepared from synthetic polymers.
本研究的目的是制备含有盐酸咪达唑仑的具有粘弹性的原位鼻腔凝胶,其粘弹性来自于无花果树(榕属,桑科)的粘胶。使用三种不同浓度(0.5%、1.0%和 1.5%w/v)的无花果树粘胶(FCM)和合成聚合物(羟丙基甲基纤维素和卡波姆 934)制备咪达唑仑鼻用凝胶。对 FCM 的评估表明,它与合成聚合物一样安全,可用于鼻腔给药。原位凝胶是用混合物 Pluronic F127 和粘膜粘附剂制备的。对所制备的凝胶进行了评价,包括粘度测定、质地分析和粘膜粘附强度。通过使用含有和不含有渗透增强剂(0.5%w/v 牛磺胆酸钠)的凝胶进行体外药物渗透研究,使用离体山羊鼻黏膜。评价了体外渗透曲线,并对渗透研究前后的鼻黏膜进行了组织学研究,以确定是否有任何组织学变化。在兔子中的体内实验进一步证实,与由合成粘膜粘附聚合物制备的凝胶相比,原位鼻腔凝胶提供了更好的咪达唑仑生物利用度。观察到含有 0.5%FCM 和 0.5%牛磺胆酸钠的鼻腔凝胶表现出适当的流变学、机械和粘膜粘附性能,并显示出更好的药物释放曲线。此外,与由合成聚合物制备的凝胶相比,该制剂对用于渗透研究的鼻黏膜没有造成损伤,并且绝对生物利用度也更高。